If you cannot find what you are looking for, get in touch at [email protected]
The influential thinktank Reform has published a report highlighting the scale of follow-up backlogs in England, with ophthalmology the specialty with the most patients waiting for follow-up appointments. RCOphth Policy Manager Jordan Marshall summarises the key points from the report and what needs to happen next.
The Academy of Medical Royal Colleges (AoMRC), in partnership with NHS England, has published a new set of ‘evidence based interventions (EBI)’ including measures for ophthalmology. The guidance aims to increase ophthalmic capacity in England by improving efficiency in the referral pathways for diabetic retinopathy, glaucoma and cataracts into hospital eye services. Implementing these changes will require clinicians and commissioners to work closely together, ensuring effective pathways are developed that are properly resourced.
Thinking about a career in ophthalmology? There are resources and information to help you along your decision to specialise.
NICE published the Selective laser therapy recommended to treat glaucoma and ocular hypertension Guidance in January 2022. The Royal College of Ophthalmologists provided a response to the NICE consultation on the new guidance and our comments and feedback were acknowledged by NICE. We outline the main areas that ophthalmologists need to be aware of. The […]
In November 2022, The Royal College of Ophthalmologists Paediatric Sub-committee held a series of focus groups to explore the challenges facing paediatric eye care and identify possible solutions to secure the future of the workforce. Following the conclusion of these focus groups, the RCOphth has produced several reports detailing key findings related to the challenges faced by the paediatric workforce alongside recommendations for policy development. We summarise these findings and recommendations below, and set out how the College intends to take this work forward in the coming months.
Boric acid and disodium tetraborate are used as excipients in a number of medicines for their antimicrobial and buffering properties. Toxicity studies in rats identified that testicular toxicity leading to reduced fertility occurs at doses below that which result in damage to other organs. As a result, the European Medicines Agency (EMA) has recommended upper limits on the daily exposure to boron-containing excipients, expressed as equivalent doses of elemental boron. For children under 2 years, the limit is 1mg per day and for children aged 2-12 years, the limit is 3mg per day. (Reference: EMA/CHMP 619104/2013).
